학술논문
A multicenter cohort study of osimertinib compared with afatinib as first-line treatment for EGFR-mutated non-small-cell lung cancer from practical dataset: CJLSG1903
Document Type
Article
Author
Source
In ESMO Open June 2021 6(3)
Subject
Language
ISSN
2059-7029